Carfilzomib Plus Dexamethasone in Previously Treated Multiple Myeloma
On January 21, 2016, carfilzomib (Kyprolis) was approved for use in combination with dexamethasone in patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy.
The ASCO Post
In The News
American Society of Hematology 2016 Annual Meeting American Society of Hematology 2016 Annual Meeting American Society of Hematology 2016 Annual Meeting American Society of Hematology 2016 Annual Meeting American Society of Hematology 2016 Annual Meeting